Issued Patents All Time
Showing 25 most recent of 49 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12194032 | Method of treating focal segmental glomerulosclerosis | Zhenhua Miao, Rajinder Singh | 2025-01-14 |
| 11883391 | Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-IL-23 blocking antibodies | James J. CAMPBELL, Israel Charo, Rajinder Singh, Yibin Zeng, Penglie Zhang | 2024-01-30 |
| 11844790 | Methods of treating hidradenitis suppurativa | Shijie LI, Rajinder Singh, Peter Staehr | 2023-12-19 |
| 11744822 | Reducing tumor burden by administering CCR1 antagonists in combination with PD-1 inhibitors or PD-L1 inhibitors | Israel Charo, Heiyoun Jung, Penglie Zhang | 2023-09-05 |
| 11382915 | Treatment of focal segmental glomerulosclerosis with CCR2 antagonists | Zhenhua Miao, Rajinder Singh | 2022-07-12 |
| 11324736 | Method of Treating Focal Segmental Glomerulosclerosis | Zhenhua Miao, Rajinder Singh | 2022-05-10 |
| 11304952 | Combination therapy using a chemokine receptor 2 (CCR2) antagonist and a PD-1/PD-L1 inhibitor | James J. CAMPBELL, Zhenhua Miao, Israel Charo, Shijie LI, Christine Janson +2 more | 2022-04-19 |
| 11045469 | Compositions and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of C-C chemokine receptor type 9 (CCR9) and anti-α4β7 integrin blocking antibodies | James J. CAMPBELL, Israel Charo | 2021-06-29 |
| 11020394 | Compositions and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of C—C chemokine receptor type 9 (CCR9) and anti-α4β7 integrin blocking antibodies | Yibin Zeng, Penglie Zhang, Israel Charo, James J. CAMPBELL | 2021-06-01 |
| 10973809 | Method of treating focal segmental glomerulosclerosis | Zhenhua Miao, Rajinder Singh | 2021-04-13 |
| 10792360 | Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-TNF-alpha blocking antibodies | James J. CAMPBELL | 2020-10-06 |
| 10758540 | Treatment of focal segmental glomerulosclerosis with CCR2 antagonists | Zhenhua Miao, Rajinder Singh | 2020-09-01 |
| 10568870 | Reducing tumor burden by administering CCR1 antagonists in combination with PD-1 inhibitors or PD-L1 inhibitors | Israel Charo, Heiyoun Jung, Penglie Zhang | 2020-02-25 |
| 8642808 | Bis-aryl sulfonamides | Solomon Ungashe, Zheng Wei, John J. Wright, Andrew Pennell, Brett Permack | 2014-02-04 |
| 8637043 | Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof | Zhenhua Miao, Robert Berahovich, Zheng Wei, Maureen Howard, Brett Premack | 2014-01-28 |
| 8343492 | Method for blocking binding of CX3C chemokines using CX3C chemokine antibodies | Gerard T. Hardiman, Devora L. Rossi, Kevin B. Bacon, J. Fernando Bazan, Albert Zlotnik | 2013-01-01 |
| 7871619 | Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors | Jennifer M. Burns, Bretton Summers, Maureen Howard, Zhenhua Miao | 2011-01-18 |
| 7785804 | Mammalian CX3C chemokine antibodies | Gerard T. Hardiman, Devora L. Rossi, Kevin B. Bacon, J. Fernando Bazan, Albert Zlotnik | 2010-08-31 |
| 7777009 | Compositions for detecting and treating diseases and conditions related to chemokine receptors | Jennifer M. Burns, Bretton Summers, Maureen Howard | 2010-08-17 |
| 7741519 | Bis-aryl sulfonamides | Solomon Ungashe, Zheng Wei, John J. Wright, Andrew Pennell, Brett Permack | 2010-06-22 |
| 7678891 | Antibodies that bind CCX-CKR2 | Maureen Howard | 2010-03-16 |
| 7649011 | Inhibitors of human tumor-expressed CCXCKR2 | Anita Melikian, Jennifer M. Burns, Brian E. McMaster, J.J. Wright | 2010-01-19 |
| 7585502 | Mammalian CX3C chemokine antibodies | Gerard T. Hardiman, Devora L. Rossi, Kevin B. Bacon, J. Fernando Bazan, Albert Zlotnik | 2009-09-08 |
| 7572600 | Enzymatic activities in chemokine-mediated inflammation | Robert Berahovich, Zhenhua Miao, Brett Premack | 2009-08-11 |
| 7442512 | Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors | Jennifer M. Burns, Zhenhua Miao, Zheng Wei, Maureen Howard, Brett Premack | 2008-10-28 |